Fujian Aonong Biological Technology Grouporp (SHSE:603363) Debt-to-Equity : -6.21 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Fujian Aonong Biological Technology Grouporp Debt-to-Equity?

Fujian Aonong Biological Technology Grouporp's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥5,960 Mil. Fujian Aonong Biological Technology Grouporp's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥2,110 Mil. Fujian Aonong Biological Technology Grouporp's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥-1,300 Mil. Fujian Aonong Biological Technology Grouporp's debt to equity for the quarter that ended in Mar. 2024 was -6.21.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Fujian Aonong Biological Technology Grouporp's Debt-to-Equity or its related term are showing as below:

SHSE:603363' s Debt-to-Equity Range Over the Past 10 Years
Min: -8.36 Med: 1.68 Max: 9.88
Current: -6.21

During the past 11 years, the highest Debt-to-Equity Ratio of Fujian Aonong Biological Technology Grouporp was 9.88. The lowest was -8.36. And the median was 1.68.

SHSE:603363's Debt-to-Equity is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 0.41 vs SHSE:603363: -6.21

Fujian Aonong Biological Technology Grouporp Debt-to-Equity Historical Data

The historical data trend for Fujian Aonong Biological Technology Grouporp's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fujian Aonong Biological Technology Grouporp Debt-to-Equity Chart

Fujian Aonong Biological Technology Grouporp Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

1.85

2.18

7.07

3.58

-8.36

Fujian Aonong Biological Technology Grouporp Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															4.12	5.75	8.12	-8.36	-6.21

Competitive Comparison of Fujian Aonong Biological Technology Grouporp's Debt-to-Equity

For the Farm Products subindustry, Fujian Aonong Biological Technology Grouporp's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fujian Aonong Biological Technology Grouporp's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Fujian Aonong Biological Technology Grouporp's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Fujian Aonong Biological Technology Grouporp's Debt-to-Equity falls into.

Fujian Aonong Biological Technology Grouporp Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Fujian Aonong Biological Technology Grouporp's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5707.081	+	2344.807)	/	-962.969
	=	-8.36

Fujian Aonong Biological Technology Grouporp's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5959.98	+	2109.809)	/	-1300.31
	=	-6.21

Fujian Aonong Biological Technology Grouporp (SHSE:603363) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Fujian Aonong Biological Technology Grouporp Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Fujian Aonong Biological Technology Grouporp's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Fujian Aonong Biological Technology Grouporp (SHSE:603363) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Fujian Aonong Biological Technology Group Incorp Ltd (SHSE:603363) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

Guanyinshan Operation Center, 12th Floor, Building 10, Siming District, Fujian Province, Xiamen, CHN, 361008

Website

http://www.aonong.com.cn

Fujian Aonong Biological Technology Group Incorp Ltd is an agricultural and animal husbandry enterprise in China. The principal business activities of the company include feed-oriented service, animal protection, pig raising, and raw material trade. In addition, the company's insurance business mainly relies on the feed marketing system throughout the country to provide downstream farmers with relevant products for disease prevention and control.

Fujian Aonong Biological Technology Grouporp (SHSE:603363) Headlines

No Headlines